CEPI Clinical Development Award — Focus Area 2
Funds organizations conducting clinical trials of vaccine candidates against CEPI priority pathogens and viral families through CEPI's Innovations Call for Proposals.
The CEPI Clinical Development Award – Focus Area 2 is a grant administered by the Coalition for Epidemic Preparedness Innovations (CEPI), a non-profit international association headquartered in Oslo, Norway, with offices in London and Washington, DC. It is one of three award tiers under CEPI's Innovations to Prepare for Future Epidemics and Pandemics call (Focus Area 2), which seeks to advance new…
Clinical testing of vaccine candidates for Lassa Fever, Disease X exemplar vaccines (up to Phase II for select prototype viruses), and other CEPI priority pathogens including paramyxoviruses, arenaviruses, coronaviruses (non-ACE-2 binding Sarbecoviruses), phenuiviruses, and nairoviruses. Covers Phase I through Phase III studies, production of clinical trial material, immunobridging studies, and CMC development.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up